Perspective Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Core Insights - Perspective Therapeutics, Inc. is a radiopharmaceutical company focused on advanced cancer treatment applications [3] - The company will present at the 43rd Annual J.P. Morgan Healthcare Conference and the Biotech Showcase in January 2025 [1][2] Company Overview - Perspective Therapeutics specializes in developing radiopharmaceuticals using the alpha-emitting isotope Pb to target cancer cells [3] - The company is also working on complementary imaging diagnostics to personalize treatment and improve patient outcomes through a "theranostic" approach [3] Clinical Development - The company's melanoma (VMT01) and neuroendocrine tumor (VMT-α-NET) programs are currently in Phase 1/2a trials at leading academic institutions [4] - Perspective has developed a proprietary Pb generator to secure key isotopes for clinical trials and commercial operations [4]